Teva Pharmaceutical Q4 2022 Earnings Results | Financial Presentation

Teva Pharmaceutical Industries presented fourth quarter and full year 2022 financial results on February 8, 2023, detailing performance across its generic and specialty pharmaceutical portfolio including products such as AUSTEDO, AJOVY, and COPAXONE. The presentation addresses key business challenges including competition in generic markets, substantial debt management, and ongoing litigation matters.